FDA Approves First Over-the-Counter Naloxone Nasal Spray

The FDA approved naloxone 4mg nasal spray for over- the-counter non-prescription use, demonstrating the FDA”s commitment to ensuring greater access to naloxone across the U.S. It will be sold directly to consumers in places such as pharmacies, convenience stores, grocery stores, gas stations, and online. The timeline for availability and price is still to be determined.

Learn more: FDA News Release